Tranexamic Acid
NDC 60505-6169, tranexamic acid, injection, solution, from Apotex Corp..
- Product NDC
- 60505-6169
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209860
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6169 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRANEXAMIC ACID100 mg/mL
Pharmacologic classes
Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-6169-1 | 60505616901 | 10 VIAL in 1 CARTON (60505-6169-1) / 10 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a93d6ef3-e160-db0d-142f-9b91af8d8428NADAC price for package 60505616901
GET /v1/drugs/nadac/60505616901
Use it
Look up 60505-6169 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6169 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-6169. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.